VIDEO DOI: https://doi.org/10.48448/wptw-gf07
July 11, 2022
Atlanta, United States
The Dramatic Fat Mass Loss Caused by Bimagrumab is Similar in Diabetic and Non-diabetic Patients.
Next from ENDO 2022
Insulin Use Among Asian and Pacific Islander Adults with Diabetes Receiving Pharmacotherapy
11 July 2022